Selecting the optimal treatment for glucocorticoid-induced osteoporosis

Joint Bone Spine. 2011 Dec:78 Suppl 2:S218-21. doi: 10.1016/S1297-319X(11)70009-4.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Anti-Inflammatory Agents / adverse effects*
  • Bone Density Conservation Agents / therapeutic use
  • Bone Resorption / prevention & control
  • Dietary Supplements
  • Female
  • Fractures, Spontaneous / prevention & control
  • Glucocorticoids / adverse effects*
  • Humans
  • Male
  • Osteoporosis / chemically induced*
  • Osteoporosis / diagnosis
  • Osteoporosis / prevention & control*
  • Osteoporotic Fractures / prevention & control
  • Risk Factors

Substances

  • Anti-Inflammatory Agents
  • Bone Density Conservation Agents
  • Glucocorticoids